Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 230 for “"VLP"”.
-
Hepatitis B core (HBc) virus like particle (VLP) as a platform for innovation of chimeric adjuvant-free VLP vaccines targeting oncoviruses
… Hepatitis B core (HBc) virus like particle (VLP) as a platform for innovation of chimeric adjuvant-free VLP vaccines targeting oncoviruses. Two chimeric HBc VLP-based vaccines presenting Epstein–Barr virus nuclear antigen 1 (EBNA1) epitope (short and non-structural epitope) and Hepatitis C …
-
VACCINE DEVELOPMENT BASED ON VIRUS-LIKE PARTICLES AND VLP DISPLAY
Virus-like particles (VLPs) from Acinetobacter phage 205 (AP205) are highly immunogenic and stable protein superstructures formed from assembly-competent viral capsid proteins and are non-infectious and replication-deficient. The AP205 VLP disassembly and reassembly protocol had high yield and …
-
Harnessing the innate immune system for improved VLP-based immunotherapy
… an attractive alternative. Virus-like particles (VLPs) have emerged as a promising alternative due to their excellent safety profile and remarkable immunogenicity.</p> <p>Recently, the successful concept of educating the immune system to fight infectious diseases has been expanded not only to …
-
Pre-clinical and clinical evaluation of the malaria vaccines RH5-VLP and PfSPZ vaccine
<p>Despite progress through expanded use of bed nets and anti-malarial drugs, <em>Plasmodium falciparum</em> (Pf) malaria caused about 200 million cases and 500,000 deaths in 2015. An ideal vaccine would reduce the burden of disease and interrupt transmission. Despite decades of effort, there is no …
-
Towards a novel and safe EVA71 VLP vaccine: Enhancing capsid stability with thermal selection
… recombinant vaccines, or virus-like particles (VLPs). However, except the inactivated vaccines, all of them are in the early stages of development. The inactivated vaccines, based on formaldehyde-inactivated viruses, were licensed and used effectively in China, the country that suffers the most …
-
Towards a novel polio VLP vaccine: Stabilising the PV-1 capsid by thermal selection.
… potential for expression of thermally-stable VLPs in yeast is also discussed.
-
The construction and characterization of a synthetic SARS VLP comprised of betacoronavirus consensus sequence-encoded viral components
… universal protection. Virus-like particles (VLPs) have been shown to be a highly safe and promising vaccine platform that can mimic the native virus and activate an immune response comparable to natural infections. This project will explore whether a consensus sequence based on the …
-
Polyomavirus-abgeleitete Virus-ähnliche Partikel als potentielle Impfstoffe
… Eigenschaften stellen Virus-ähnliche Partikel (VLP) interessante Träger zur Entwicklung neuer Impfstoffe dar. Zielstellung: Das Ziel der Untersuchungen bestand in der Herstellung und Charakterisierung von autologen Polyomavirus-VLP und chimären Hamsterpolyomavirus (HaPyV)-abgeleiteten VLP. …
-
Immunogenicity of antigen-displaying virus-like particles and their use as a potential vaccine against prion diseases
… strategy based on virus-like particles (VLP) to induce anti-PrPC antibody responses in PrPC-competent mice. In a first step it was assessed whether VLP have the capacity to induce antibody responses that are protective against conventional pathogens. For this purpose, VLP displaying the …
-
Virus-ähnliche Partikel auf Basis des Hamster-Polyomavirus als potentielle Träger für den Gentransfer
… Virus-ähnlichen Partikeln (virus like particles, VLP) dar. Ein möglicher Ausgangspunkt für die Entwicklung von VLP für eine gentherapeutische Anwendung ist das Hauptkapsidprotein VP1 des Hamsterpolyomavirus (HaPyV), das nach heterologer Expression in der Hefe Saccharomyces cerevisiae zu VLP …
-
Visible Light Positioning for Robotic Navigation
… are unreliable. Visible Light Positioning (VLP) has emerged as a promising solution, leveraging the ubiquity of Light Emitting Diode (LED) lighting and low-cost photodiode receivers to provide centimeter-level accuracy. Despite its potential, two key barriers have limited progress: the …
-
Angular Diversity Based Visible Light Positioning
Visible Light Positioning (VLP) uses modulated LED luminaries to help locate a receiver inside a building. Indoor positioning is becoming an increasingly important service, and visible light has many advantages over other technologies used in indoor positioning systems (IPS). However existing VLP …
-
Online robust nonblocking supervisory control of discrete-event systems
… in the form of a variable lookahead policy (VLP). In this approach, the supervisory commands are computed online when the plant is in operation, based on the behavior of the plant models in the near future (lookahead window). In this way, only the plant models need to be stored in computer …
-
Novel visible light positioning techniques : a thesis presented in partial fulfilment of the requirements of the degree of Doctor of Philosophy in Department of Mechanical and Electrical Engineering at Massey University, Albany, New Zealand
… area of research. Visible Light Positioning (VLP) has been getting the attention of researchers due to several advantageous factors. VLP is more accurate than many of the competing techniques. As Light Emitting Diode (LED) based luminaires have become an integral part of the indoor lighting …
-
Integration of virus-like particle macromolecular bioreceptors in electrochemical biosensors
… Tobacco mosaic virus-like particle (TMV VLP) biosensing receptor, and the microsystem integration of VLPs in microfabricated electrochemical biosensors for rapid and performance-enhanced chemical and biological sensing. Two constructs of VLPs carrying different receptor peptides targeting …
-
ROLE OF THE MUCOSAE-ASSOCIATED EPITHELIAL CHEMOKINE (MEC/CCL28) IN THE MODULATION OF THE IMMUNE RESPONSE AGAINST VIRAL INFECTIONS
… mucosal lamina propria. Virus-like particles (VLPs) are a novel vaccine approach based on non-pathogenic particles that mimic the structure of authentic virus particles. Immunogenicity of vaccines can be improved by the use of chemokine molecular adjuvants. Here we propose experimental …
-
Investigating Genetically Engineered Virus-Like Particles Using Molecular Dynamics Simulations for Enhanced Vaccine Development
Virus-like particles (VLPs) mimic the structure of viruses without containing viral genetic material, making them safe and highly immunogenic platforms for vaccine development. Genetic modifications can expand the use of VLPs, such as the insertion of antigens to target various diseases. However, …
-
Structural insight into the type-specific epitope of porcine circovirus type-3 (PCV3)
… of self-assembly into virus-like-particles (VLPs), which is validated by transmission electron microscopy and dynamic light scattering assays. Moreover, the epitope of 1H1 was identified in the CD-loop region on the VLP surface, which is confirmed by PCV2-PCV3 epitope swapping assay. For the …
-
Biochemical Investigation of the Intracellular Trafficking of Non-Viral and Hybrid Gene Therapy Vectors
… thereby estimating endosomal escape of VLP. MLV were observed to achieve reverse transcription rapidly, with more than half of infecting viruses being reverse transcribed within 8 hours. PEI:VLP were delayed approximately 4 hours (relative to viruses) in having their RNA reverse …
Page 1 of 12